Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound.
Drug patent litigation for PALBOCICLIB.
This ingredient has one hundred and forty-four patent family members in fifty-five countries.
Three suppliers are listed for this compound. There are four tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
